Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Van Tine

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
MLO: Medical Laboratory Observer|September 26, 2014
Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancerBrian A Van Tine
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2024
Is It Time to Resist Using RECIST as a Primary Endpoint for Rare Tumor Trials?Brian A Van Tine, Sasha Haarberg
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
Immune checkpoint inhibitor resistance in soft tissue sarcomaVanessa Eulo, Brian A Van Tine
Journal of Clinical Medicine|April 3, 2021
Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future TherapiesRicha Rathore, Brian A Van Tine
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2022
In an Era of ctDNA, Is Metabolomics the New Kid on the Block?Brian A Van Tine, Costas A Lyssiotis
Current Treatment Options in Oncology|March 3, 2023
Relapsed Synovial Sarcoma: Treatment OptionsMia C Weiss, Brian A Van Tine
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2022
Are the Pieces Starting to Come Together for Management of Desmoid Tumors?Anna C Greene, Brian A Van Tine
Current Medical Research and Opinion|January 18, 2019
How we use pazopanib in treating soft-tissue sarcoma: experience at our multidisciplinary sarcoma centersBrian A Van Tine, Jonathan C Trent
JACC. Cardiooncology|March 6, 2023
More Data to Support a Cardiac-Oncologic PartnershipRonald J Krone, Brian A Van Tine
Journal of the National Cancer Institute|March 31, 2011
Understanding the estrogen receptor-positive breast cancer genome: not even the end of the beginningBrian A Van Tine, Matthew J Ellis
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
MLO: Medical Laboratory Observer|September 26, 2014
Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancerBrian A Van Tine
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2024
Is It Time to Resist Using RECIST as a Primary Endpoint for Rare Tumor Trials?Brian A Van Tine, Sasha Haarberg
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
Immune checkpoint inhibitor resistance in soft tissue sarcomaVanessa Eulo, Brian A Van Tine
Journal of Clinical Medicine|April 3, 2021
Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future TherapiesRicha Rathore, Brian A Van Tine
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2022
In an Era of ctDNA, Is Metabolomics the New Kid on the Block?Brian A Van Tine, Costas A Lyssiotis
Current Treatment Options in Oncology|March 3, 2023
Relapsed Synovial Sarcoma: Treatment OptionsMia C Weiss, Brian A Van Tine
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2022
Are the Pieces Starting to Come Together for Management of Desmoid Tumors?Anna C Greene, Brian A Van Tine
Current Medical Research and Opinion|January 18, 2019
How we use pazopanib in treating soft-tissue sarcoma: experience at our multidisciplinary sarcoma centersBrian A Van Tine, Jonathan C Trent
JACC. Cardiooncology|March 6, 2023
More Data to Support a Cardiac-Oncologic PartnershipRonald J Krone, Brian A Van Tine
Journal of the National Cancer Institute|March 31, 2011
Understanding the estrogen receptor-positive breast cancer genome: not even the end of the beginningBrian A Van Tine, Matthew J Ellis
Pageof 15